Navigation Links
EnVivo Pharmaceuticals Announces Results and Successful Completion of EVP-6124 Phase Ib/IIa Trial at the International Conference on Alzheimer's Disease
Date:7/15/2009

and executive function. Four of the eight cognition measures showed statistically significant dose-dependent effects and two others showed a trend towards improvement.

Based on the success of the trial, EnVivo plans to proceed to larger and longer Phase 2 studies to better define both the pro-cognitive effects of EVP-6124 as well as to measure its potential clinical benefit.

About EnVivo Pharmaceuticals

EnVivo Pharmaceuticals, located in Watertown, Mass., is a biopharmaceutical company dedicated to discovering and developing small molecule therapeutics for disorders of the central nervous system, with a current focus on Alzheimer's disease, Cognitive Disorders and Schizophrenia. The company's lead product is an alpha-7 nicotinic acetylcholine receptor agonist and has been tested in Phase IIa clinical trials for cognition disorders in Alzheimer's disease and Schizophrenia. The company's other programs include an epigenetics program based on Histone Deacetylase inhibition (HDACi) with EVP-0334 as the lead molecule for cognition in Alzheimer's disease which is in Phase I studies, and several preclinical programs such as a Gamma Secretase Modulator (for Alzheimer's disease) and a PDE10 inhibitor program (for schizophrenia). For more information about EnVivo, visit www.envivopharma.com.


'/>"/>
SOURCE EnVivo Pharmaceuticals
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. EnVivo Pharmaceuticals Announces Executive Appointment
2. EnVivo Pharmaceuticals Announces Reversal of Cognitive Deficits in Alzheimers Disease Transgenic Mouse Model With Gamma-Secretase Modulator
3. Vion Pharmaceuticals Pays Interest on 7.75% Convertible Senior Notes
4. China Biopharmaceuticals Holdings Announces Second Quarter 2007 Financial Results
5. Vion Pharmaceuticals Completes Accrual of 85 Patients to its Pivotal Phase II Trial of Cloretazine(R) (VNP40101M) in Elderly AML
6. XTL Biopharmaceuticals Announces Financial Results for the Six Months Ended June 30, 2007
7. Cadence Pharmaceuticals Reports Second Quarter 2007 Financial Results
8. Nabi Biopharmaceuticals to Present at Upcoming Industry Conferences
9. Anadys Pharmaceuticals Appoints Steve Worland, Ph.D. as President and Chief Executive Officer
10. Poniard Pharmaceuticals Announces Participation in Upcoming Conferences
11. NovaQuest Advances Virtual Development Model With Strategic Investment in TOPIGEN Pharmaceuticals
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/15/2014)...  iVinci Health LLC, the company behind the healthcare ... branded as VisitPay®, has successfully closed $5 million in ... a new extension to VisitPay® – an online Payment ... way for patients to manage their medical bills and ... their families. The new round of funding, ...
(Date:9/15/2014)... 2014 Applied Silicone Corporation, a ... the medical device and critical healthcare market, introduces ... implantable medical device market. The Dual Matrix ... a silicone gel with improved fracture resistance, cohesive ... consists of two crosslinked networks working in conjunction ...
(Date:9/15/2014)... ANNAPOLIS, Maryland , 15 de septiembre de 2014 /PRNewswire/ ... se llevará a cabo del 12 al 18 de ... Association (PPTA) y de sus compañías miembro s, ... de la concienciación mundial en torno a la colección de ... los donantes de plasma al salvar y mejorar las vidas ...
(Date:9/14/2014)... 15, 2014 UMBC’s Biotechnology Graduate ... Tuesday, October 21, 2014, from 12:00 to 1:00 p.m. ... program’s innovative curriculum and practice-oriented instruction, designed for working ... can help advance their career in the biotechnology industry. ... . , About UMBC’s Biotechnology Graduate Programs, UMBC ...
Breaking Biology Technology:iVinci Health Raises $5M to Fuel National Expansion, Announces Launch of Personal Finance Portal for Healthcare 2iVinci Health Raises $5M to Fuel National Expansion, Announces Launch of Personal Finance Portal for Healthcare 3Applied Silicone Launches Silicone Gel System with Dual Matrix Technology 2La International Plasma Awareness Week será una celebración para los donantes 2La International Plasma Awareness Week será una celebración para los donantes 3UMBC Biotechnology Graduate Programs’ Virtual Info Session, October 21, 2014 2
... organizations see security and compliance as their top issues, they ... There is a big secret that few executives know about ... issue. It goes beyond knowing virus scans and firewalls. Security ... strategy and not a low-level function. , ,In several semesters ...
... trend away from IPOs and the progress of six regional ... Fund I annual meeting, held at the Wisconsin Athletic Club. ... Mason Wells met in Milwaukee to hear a speech ... Association , and listen to updates from six firms that ...
... Bone Care International Inc. announced on Wednesday that the ... ,Genzyme and Bone Care have signed a definitive agreement for ... transaction valued at $33.00 per fully diluted share. ... Care's shareholders at a meeting on June 30, and other ...
Cached Biology Technology:To find solid security candidates, look beyond tech certificates 2To find solid security candidates, look beyond tech certificates 3To find solid security candidates, look beyond tech certificates 4VC trends, company progress discussed at Mason Wells portfolio meeting 2VC trends, company progress discussed at Mason Wells portfolio meeting 3VC trends, company progress discussed at Mason Wells portfolio meeting 4
(Date:9/15/2014)... teeming with life it,s not what comes to mind ... time evidence of Doncaster,s 310-million-year-old past, including a fossilised shark ... , Some of the fossilised plants and creatures may even ... case, several horseshoe crabs and some previously unrecorded seed pods ... rocks that formed within the coal and shale deposits in ...
(Date:9/15/2014)... Amid conflicting reports about the need for vitamin ... published today suggests that adequate levels of this essential ... elderly, and women who are or may become pregnant. ... also important, researchers said, but often complicated by the ... difficult to obtain through diet alone. It has been ...
(Date:9/12/2014)... September 12, 2014 ... the addition of the  "Global Facial Recognition ... and Facial Analytics) - Industry Analysis, Size, ... 2020"  report to their offering. ... facial recognition market was valued at USD ...
Breaking Biology News(10 mins):'Jaws' lived in Doncaster 2Vitamin E intake critical during 'the first 1,000 days' 2Vitamin E intake critical during 'the first 1,000 days' 3Global Facial Recognition Market (2D Facial Recognition, 3D Facial Recognition, and Facial Analytics) - Trends and Forecast to 2020 2Global Facial Recognition Market (2D Facial Recognition, 3D Facial Recognition, and Facial Analytics) - Trends and Forecast to 2020 3
... As governments prepare to gather at the United ... and 20, a new report published by a group ... evidence that a combined approach to tackling poverty and ... education, and nutrition/food securityachieves better results for the world,s ...
... which extends to include the formal scientific naming of all ... in the procedure scientists need to follow when they describe ... ,International Code of Nomenclature for algae, fungi and plants, are ... article published in BioMed Central,s open access journal BMC ...
... for Research on Aging (Novato, CA) and Biotica Technology ... investigate polyketides in diseases of aging. Building on observations ... & Kennedy; Nature 2009), the collaborators will ... range of age-related disease models to identify novel therapeutics. ...
Cached Biology News:Report showcases success of integrated development approaches 2Report showcases success of integrated development approaches 3Bringing botany into the 21st Century 2Buck Institute and Biotica to investigate polyketides in extension of healthy lifespan 2